SAN FRANCISCO — Anthropic announced the availability of Claude Science, an application designed for use in scientific laboratories and pharmaceutical research operations, on June 30, 2026. The application is available in beta to users with Pro, Max, Team, and Enterprise subscriptions.

Claude Science functions as an AI workbench that connects to more than 60 scientific databases. It includes pre-built toolkits for fields such as genomics, protein structure, and chemistry. The application employs a separate fact-checker AI to verify citations and calculations, though this process utilizes the same underlying model and not an independent source.

The system can generate figures, such as 3D protein structures, along with the code used to create them. These generated figures include the exact code, environment, a plain-language description, and the full message history. Users can modify figures using plain language prompts that adjust the underlying code.

Claude Science is designed to run on a laboratory's local infrastructure, which can prevent data from being sent to Anthropic's servers. Eric Kauderer-Abrams, Anthropic's head of life sciences, stated that he feels the company's efforts in biology are "the single most important thing" at Anthropic.

The new application does not feature a new AI model but runs on existing Claude models, including Claude Opus 4.8. Anthropic is offering support for up to 50 Claude Science projects with up to $30,000 in credits per project. Applications for this credit program are open until July 15, 2026, with award notifications scheduled for July 31, 2026.

Sean Whalen, a principal scientist at Gladstone Institutes, used Claude Science to build a genome browser. Jérôme Lecoq, a neuroscientist at the Allen Institute, utilized the application to develop a multi-agent computational review pipeline. Anthropic launched Claude for Life Sciences in October 2025. One month prior to the Claude Science announcement, Anthropic reported annualized sales of $42 billion and was valued at $965 billion following a $65 billion funding round.